• NADPH Oxidase ROS Activate Ca2+ Channels in Rat Arteries

  2026-09-01

  The reference study identifies L-type voltage-gated Ca2+ channels as the principal downstream route by which NADPH oxidase-derived ROS enhance arterial contraction in early postnatal rats. Pharmacological comparison showed that this effect persisted after Rho-kinase, PKC, or Src-kinase inhibition but disappeared with L-type Ca2+ channel blockade, providing a useful framework for interpreting ROS-dependent vascular tone.

• nPEC for Dual-Loaded Liposome Analysis

  2026-08-31

  A 2025 Journal of Pharmaceutical Sciences study systematically compared methods for measuring encapsulation efficiency in liposomes carrying both hydrophilic and lipophilic drugs. Its validation of nanoparticle exclusion chromatography (nPEC) provides a practical, broadly applicable route for simultaneous analysis without extensive sample pretreatment.

• Panobinostat (LBH589) Research Workflows

  2026-08-31

  Panobinostat (LBH589) links broad HDAC inhibition to measurable chromatin, apoptotic, and extracellular-matrix phenotypes. This practical guide shows how to build cancer and scleral macrophage workflows around the compound while separating validated findings from optimization starting points.

• DIDS: From Chloride Transport to Metastatic States

  2026-08-30

  DIDS is more than a conventional chloride channel blocker: it is a broad mechanistic probe that can connect ion transport, mitochondrial stress, tumor-cell survival, and translational assay design. This article examines how DIDS can be used to interrogate prometastatic states while preserving appropriate controls for specificity, formulation, and biological interpretation.

• Pretomanid Inhibits Both TB Terminal Oxidases

  2026-08-29

  The reference study identifies the cytochrome bcc:aa3 and bd terminal oxidases as functional respiratory targets of pretomanid, also known as PA-824. Its genetic and chemical biology evidence supports rational combinations with telacebec and ND-011992 to improve bactericidal activity against replicating and antibiotic-tolerant Mycobacterium tuberculosis while limiting resistance emergence.

• GSK621: Reading AMPK in Immunometabolic Assays

  2026-08-28

  GSK621 is a potent AMPK agonist for resolving energy-sensing, autophagy, lipid metabolism, and leukemia-associated phenotypes. This article presents an assay-architecture framework that separates AMPK pathway activation from cell-state interpretation and connects AML findings with immunometabolic research.

• Vancomycin Workflows for Microbiome Research

  2026-08-28

  Learn how to deploy Vancomycin as a controlled bacterial cell wall perturbation tool in MRSA, resistance, and microbiome–immune experiments. This workflow-focused guide connects peptidoglycan precursor binding with practical culture assays, antibiotic-perturbation controls, and troubleshooting for immune readouts.

• Oseltamivir Acid: Assay-to-Model Translation

  2026-08-27

  Oseltamivir acid is an influenza neuraminidase inhibitor whose value depends on connecting enzyme inhibition with cellular, resistance, and translational readouts. This article presents an assay-to-model framework informed by humanized-mouse pharmacokinetic research, while clearly separating direct evidence from practical recommendations.

• Ethacridine lactate monohydrate in Cell Assays

  2026-08-27

  Ethacridine lactate monohydrate offers a practical microbial-control variable for sensitive stem-cell, chromatin, and biochemical workflows. Its aqueous and DMSO solubility support formulation screening, while compatibility controls help distinguish antiseptic effects from genuine YAP-TEAD and super-enhancer biology.

• Dual-Readout mRNA for Translational Delivery

  2026-08-26

  A mechanistic and strategic guide to using dual-fluorescence reporter mRNA to separate nanoparticle uptake from productive translation, strengthen assay design, and accelerate targeted mRNA delivery decisions.

• Tobramycin: From Ribosome Mechanism to Translation

  2026-08-26

  Tobramycin is more than an aminoglycoside antibiotic: it is a defined perturbation tool for studying bacterial protein synthesis, Gram-negative microbiology, and resistance phenotypes. This thought-leadership guide connects historical comparative evidence with practical assay design, product-selection considerations, and a disciplined translational outlook.

• Central Control of Opioid Mechanical Hypersensitivity

  2026-08-25

  A 2024 Neuron study identifies a lateral parabrachial nucleus–hypothalamus–spinal dorsal horn pathway that controls morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. Its findings separate mechanical opioid side effects from better-established thermal mechanisms and provide a circuit-level framework for testing μ-opioid receptor dependence.

• Iron Stress Reprograms Enterocyte Metabolism

  2026-08-25

  Navazesh and Ji show that both iron deficiency and iron excess produce distinct metabolic and transcriptional states in IPEC-J2 enterocytes. Their combination of bidirectional iron manipulation, inflammatory challenge, time-course gene analysis, and untargeted metabolomics provides a useful framework for studying how intestinal epithelial cells adapt to iron stress.

• MK-8745: Aurora A Inhibitor Workflow Guide

  2026-08-24

  MK-8745 is a potent, selective Aurora A inhibitor for connecting kinase inhibition with mitotic arrest, tetraploidy, and apoptosis in cancer models. This workflow guide covers formulation, cell-based assay design, non-Hodgkin lymphoma applications, retinoblastoma translation, and xenograft study planning.

• Torin2 Assay Design: Distinguishing Arrest From Death

  2026-08-24

  Torin2 is a potent mTOR inhibitor for dissecting growth arrest, cell killing, and pathway-dependent responses. This guide applies a measurement framework from Schwartz’s cancer-drug research to improve viability, apoptosis assay, and medullary thyroid carcinoma experiments.

8121 records 1/542 page Next 12345 下5页 Last page